Skip to content
Disclosery

SUPERSTRING CAPITAL MANAGEMENT LP: DRUG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of SUPERSTRING CAPITAL MANAGEMENT LP on DRUG, newest first. How the timeline and the estimate are built.

SUPERSTRING CAPITAL MANAGEMENT LP held 30,456 DRUG shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 30,456 shares
    Change vs previous 13F +17,145 shares

    1.35% of the 13F portfolio, value $2,138,011.

    13F-HR 0001931118-26-000009 filed by SUPERSTRING CAPITAL MANAGEMENT LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 13,311 shares
    Change vs previous 13F -33,967 shares

    0.69% of the 13F portfolio, value $971,304.

    13F-HR 0001931118-26-000008 filed by SUPERSTRING CAPITAL MANAGEMENT LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 47,278 shares
    Change vs previous 13F -6,672 shares

    1.98% of the 13F portfolio, value $3,689,575.

    13F-HR 0001931118-26-000003 filed by SUPERSTRING CAPITAL MANAGEMENT LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 53,950 shares
    Change vs previous 13F not available

    3.22% of the 13F portfolio, value $3,272,607.

    13F-HR 0001931118-25-000010 filed by SUPERSTRING CAPITAL MANAGEMENT LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).